My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Biocept, Inc. - Common Stock (NQ:BIOC)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 24, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Biocept, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 17, 2023

Via Benzinga

6 F-Rated Penny Stocks Not Worth Your Dime ↗

January 31, 2023

Very risky, with questionable upside potential, don't waste even a nickel on these seven penny stocks to sell.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 24, 2023

We're starting the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

Via InvestorPlace

Recap: Biocept Q4 Earnings ↗

April 06, 2022

Biocept (NASDAQ:BIOC) reported its Q4 earnings results on Wednesday, April 6, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

The Jobs Report Tells A False Narrative ↗

January 19, 2023

Today's jobless claims figure was surprisingly strong despite massive layoffs. We tell the real story here.

Via Talk Markets

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 12, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 19, 2022

Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 16, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 27, 2022

During Monday's session, 77 companies made new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 08, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 24, 2022

On Friday, 61 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 07, 2022

Gainers

Via Benzinga

Biocept's Return On Capital Employed Overview ↗

May 24, 2022

According to Benzinga Pro data, during Q1, Biocept (NASDAQ:BIOC) posted sales of $19.95 million. Earnings were up 6.84%, but Biocept still reported an overall loss of $2.77 million.

Via Benzinga

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More ↗

May 22, 2022

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

Via Benzinga

Looking Into Biocept's Return On Capital Employed ↗

April 07, 2022

Benzinga Pro data, Biocept (NASDAQ:BIOC) reported Q4 sales of $13.98 million. Earnings fell to a loss of $2.97 million, resulting in a 375.6% decrease from last quarter.

Via Benzinga

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall ↗

March 31, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

Earnings Scheduled For March 31, 2022 ↗

March 31, 2022

Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

Via Benzinga

Earnings Outlook For Biocept ↗

March 30, 2022

Biocept (NASDAQ:BIOC) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Biocept will report...

Via Benzinga

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict ↗

March 30, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 22, 2022

Gainers Revelation Biosciences (NASDAQ:REVB

Via Benzinga

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients ↗

September 29, 2021

Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.